You are here

EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research

2017

Paul Caton: King's College London - UK
Inhibiting NAMPT to improve beta cell survival and function in type 1 diabetes

Rosa Gasa: IDIBAPS - Barcelona, Spain
Direct reprogramming of human fibroblasts towards insulin-producing cells

Silvia Gregori: San Raffaele Scientific Institute - Milan, Italy
Genetically engineered tolerogenic dendritic cells for antigen-specific immunotherapy for type 1 diabetes

Esteban Nicolas Gurzov: Free University Brussels - Belgium
New markers for pancreatic beta cell imaging in type 1 diabetes

Valeria Sordi: San Raffaele Scientific Institute - Milan, Italy
A role for the intestine in type 1 diabetes autoimmunity

Jorma Toppari: University of Turku - Finland
Molecular basis for aberrant immune response to microbial factors in type 1 diabetes

2016

Mario Galgani: “G Salvatore” National Research Council – Naples, Italy
CD3+CD56+ cells a novel human regulatory population: function and molecular mechanism in type 1 diabetes

Ben Giepmans: University Medical Center Groningen – The Netherlands
Do exocrine – endocrine cell interactions induce inflammatory responses leading to type 1 diabetes?

Agnes Lehuen: Cochin Institute - Paris, France
Role of MAIT cells in type 1 diabetes, studies in patients and mouse models

Christopher O’Callaghan: University of Oxford – UK
Using single-cell transcriptomics to investigate the protective role of Dexi in islet destruction in type 1 diabetes

Carlos Penha-Concalves: Gulbenkian Science Institute – Oeiras, Portugal
Genetic causes of immune-dysregulation in early-onset type 1 diabetes

Romano Regazzi: University of Lausanne – Switzerland
Role of exosome-mediated RNA transfer from immune cells to beta cells in type 1 diabetes development

2015

Yuval Dor: Hebrew University of Jerusalem - Israel
Long-term impact of premature weaning on pancreatic beta cells

Silvia Gregori: Fondazione Centro San Raffaele - Milan, Italy
Negative vaccination strategy for type 1 diabetes based on tolerogenic dendritic cells

Roberto Mallone: Cochin Institute - Paris, France
Oral vaccination with Fc-coupled preproinsulin for type 1 diabetes prevention

Geert Martens: Brussels Free University - Belgium
Combinatorial GAD65/miR-375 profiling to detect immune-mediated beta cell injury in (pre)type 1 diabetes (BetaCell-Probe)

Giuseppe Matarese: CNR - Naples, Italy
Extracellular microRNAs as molecular link between immune and metabolic dysregulation in type 1 diabetes

Nikolay Ninov: Technical University Dresden - Germany
Small molecules and pathways for boosting human beta cell regeneration and survival under inflammation

Rocky Strollo: University Campus Bio-Medico - Rome, Italy
Antibodies to posttranslationally modified insulin as biomarker of type 1 diabetes